Short Interest in MariMed Inc. (OTCMKTS:MRMD) Declines By 32.5%

MariMed Inc. (OTCMKTS:MRMD) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 44,900 shares, a decline of 32.5% from the May 15th total of 66,500 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 858,800 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Noble Financial raised shares of MariMed to a “strong-buy” rating in a research note on Thursday, April 3rd.

MariMed Stock Down 2.8%

Shares of MRMD traded down $0.00 during midday trading on Tuesday, hitting $0.07. 377,294 shares of the company’s stock traded hands, compared to its average volume of 405,356. MariMed has a 1 year low of $0.07 and a 1 year high of $0.29. The firm’s fifty day moving average is $0.09 and its 200-day moving average is $0.11. The company has a current ratio of 1.55, a quick ratio of 0.73 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $27.40 million, a price-to-earnings ratio of -1.76 and a beta of 2.99.

MariMed (OTCMKTS:MRMD) last issued its earnings results on Wednesday, May 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). The company had revenue of $37.96 million during the quarter, compared to analyst estimates of $38.33 million. MariMed had a negative return on equity of 2.75% and a negative net margin of 10.97%.

About MariMed

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.